William H. Kucheman is CEO of Boston Scientific Corporation and a member of its Board of Directors. He works with the company’s senior management team to develop principal international markets for less-invasive medical devices by establishing and marketing innovative products, services and therapies. These are designed to respond to the unmet needs of patients; offer top quality clinical outcomes and more. Other roles Kucheman has held at the company include: Executive VP and President of the Cardiology, Rhythm and Vascular (CRV) Group, putting him in charge of the company’s Interventional Cardiology and Cardiac Rhythm Management businesses and its Endovascular Unit. He has been with the company since 1995.